GEODE CAPITAL MANAGEMENT, LLC - CYCLACEL PHARMACEUTICALS INC ownership

CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 16 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$31,000
-71.3%
81,343
-50.0%
0.00%
Q4 2019$108,000
+237.5%
162,686
+100.0%
0.00%
Q3 2019$32,000
-25.6%
81,3430.0%0.00%
Q2 2019$43,000
+115.0%
81,343
+275.0%
0.00%
Q1 2019$20,000
-23.1%
21,692
-50.0%
0.00%
Q4 2018$26,000
-10.3%
43,384
+100.0%
0.00%
Q3 2018$29,000
-3.3%
21,6920.0%0.00%
Q2 2018$30,000
+3.4%
21,6920.0%0.00%
Q1 2018$29,000
-21.6%
21,6920.0%0.00%
Q4 2017$37,000
-5.1%
21,6920.0%0.00%
Q3 2017$39,000
-52.4%
21,6920.0%0.00%
Q2 2017$82,000
+17.1%
21,692
+53.9%
0.00%
Q2 2016$70,00014,0990.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 559,900$1,025,0000.31%
Virtu Financial LLC 117,644$215,0000.01%
WEDBUSH SECURITIES INC 27,400$50,0000.01%
TWO SIGMA SECURITIES, LLC 28,471$52,0000.01%
BREWIN DOLPHIN LTD 5,586$10,2220.00%
UBS Group AG 3,355$6,0000.00%
D'Orazio & Associates, Inc. 100$00.00%
DIMENSIONAL FUND ADVISORS LP 14,749$27,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 21,692$39,0000.00%
DEUTSCHE BANK AG\ 503$00.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders